Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor

Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor

US Patent 11369623 · Granted Jun 28, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic amide compounds for rabies treatment and method thereof2025
Tumor-treating pharmaceutical composition2025
Tumor-treating pharmaceutical composition2025
Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor 2024
Anti-erythropoietin receptor peptide2024
3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-c]pyridine 2023
Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor2023
3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine 2022
Prevention or treatment agent for hepatic fibrosis2019
Prevention or treatment agent for hepatic fibrosis2019
Alpha helix mimetics and methods relating thereto2018
Alpha helix mimetics and methods relating thereto2018